148 related articles for article (PubMed ID: 18836287)
1. Prognostic markers in pancreatic ductal adenocarcinomas.
Hezel AF; Bardeesy N
Cancer Biol Ther; 2008 Sep; 7(9):1360-1. PubMed ID: 18836287
[No Abstract] [Full Text] [Related]
2. Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma.
Reiser-Erkan C; Erkan M; Pan Z; Bekasi S; Giese NA; Streit S; Michalski CW; Friess H; Kleeff J
Cancer Biol Ther; 2008 Sep; 7(9):1352-9. PubMed ID: 18708761
[TBL] [Abstract][Full Text] [Related]
3. Circulating Exosomes in Pancreatic Cancer: Will They Succeed on the Long, Littered Road to Early Detection Marker?
Babic A; Wolpin BM
Clin Chem; 2016 Feb; 62(2):307-9. PubMed ID: 26721295
[No Abstract] [Full Text] [Related]
4. Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways.
Cao D; Maitra A; Saavedra JA; Klimstra DS; Adsay NV; Hruban RH
Mod Pathol; 2005 Jun; 18(6):752-61. PubMed ID: 15696124
[TBL] [Abstract][Full Text] [Related]
5. Label-free proteomics reveals serum proteins whose levels differ between pancreatic ductal adenocarcinoma patients with short or long survival.
Holm M; Saraswat M; Joenväärä S; Seppänen H; Renkonen R; Haglund C
Tumour Biol; 2020 Jun; 42(6):1010428320936410. PubMed ID: 32586207
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers in pancreatic ductal adenocarcinoma.
Gallego J; López C; Pazo-Cid R; López-Ríos F; Carrato A
Clin Transl Oncol; 2017 Dec; 19(12):1430-1437. PubMed ID: 28616721
[TBL] [Abstract][Full Text] [Related]
7. Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA.
Lee JS; Park SS; Lee YK; Norton JA; Jeffrey SS
Mol Oncol; 2019 Aug; 13(8):1623-1650. PubMed ID: 31243883
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic and Predictive Factors for Pancreatic Adenocarcinoma].
Karásek P; Hermanová M
Klin Onkol; 2016; 29(5):336-341. PubMed ID: 27739311
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers, imaging and multifocality in intraductal papillary mucinous neoplasms: relevant for decision making?
Ansari D; Aronsson L; Andersson R
Future Oncol; 2017 Aug; 13(20):1751-1753. PubMed ID: 28831817
[No Abstract] [Full Text] [Related]
10. Endoscopic Ultrasound-Guided Fine-Needle Biopsies From Pancreatic Ductal Adenocarcinomas Can Be Used to Quantify PD-L1.
Gleeson FC; Zhang L; Roden AC; Levy MJ
Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1535-1536. PubMed ID: 29306039
[No Abstract] [Full Text] [Related]
11. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
[TBL] [Abstract][Full Text] [Related]
12. Metastatic Pancreatic Cancer.
Hogendorf P; Durczyński A; Strzelczyk J
J Invest Surg; 2018 Apr; 31(2):151-152. PubMed ID: 28267398
[No Abstract] [Full Text] [Related]
13. MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma.
Vychytilova-Faltejskova P; Kiss I; Klusova S; Hlavsa J; Prochazka V; Kala Z; Mazanec J; Hausnerova J; Kren L; Hermanova M; Lenz J; Karasek P; Vyzula R; Slaby O
Diagn Pathol; 2015 Apr; 10():38. PubMed ID: 25908274
[TBL] [Abstract][Full Text] [Related]
14. Early detection and imaging strategies to reveal and target developing pancreatic cancer.
Crawford HC; Wallace MB; Storz P
Expert Rev Anticancer Ther; 2020 Feb; 20(2):81-83. PubMed ID: 31986932
[No Abstract] [Full Text] [Related]
15. Detecting and diagnosing ampullary neoplasms.
Wang LF; Hingorani SR; Tuveson DA
Cancer Biol Ther; 2004 Jul; 3(7):657-9. PubMed ID: 15326385
[No Abstract] [Full Text] [Related]
16. Prognostic Significance of Cofilin Isoforms in Patients With Pancreatic Ductal Adenocarcinoma.
Islam S; Kitagawa T; Kuramitsu Y
Pathol Oncol Res; 2021; 27():1609821. PubMed ID: 34257623
[No Abstract] [Full Text] [Related]
17. Utility of immunohistochemistry in the pancreatobiliary tract.
Lin F; Chen ZE; Wang HL
Arch Pathol Lab Med; 2015 Jan; 139(1):24-38. PubMed ID: 25549142
[TBL] [Abstract][Full Text] [Related]
18. Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis.
Jamieson NB; Carter CR; McKay CJ; Oien KA
Clin Cancer Res; 2011 May; 17(10):3316-31. PubMed ID: 21444679
[TBL] [Abstract][Full Text] [Related]
19. Significance of SATB2 expression in colon cancer and its differential diagnosis in digestive tract adenocarcinoma and ovarian primary and metastatic carcinoma.
Liu F; Gao Z; Shen D; Zhao H; Wang C; Ye Y; Ma Y; Kong F
Pathol Res Pract; 2019 Jul; 215(7):152430. PubMed ID: 31101576
[TBL] [Abstract][Full Text] [Related]
20. Analyzing miRNAs in ductal adenocarcinomas of the pancreas.
Mees ST; Schleicher C; Mardin WA; Senninger N; Colombo-Benkmann M; Haier J
J Surg Res; 2011 Aug; 169(2):241-6. PubMed ID: 20080250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]